$0.243
-0.011 (-4.59%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VTGN por análisis de gráficos similares
Alphio's VTGN stock price prediction model matches the current Vistagen Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.25 (+1.80%). The 1-week path is $0.26 (+5.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vistagen Therapeutics Inc?
Vistagen Therapeutics is currently not a strong buy. The stock is trading at $0.2529, and while it has shown a 3.65% increase over the past five days, it has a staggering year-to-date decline of 62.75%. The RSI is at 48.935, indicating a neutral position, and the forward P/E ratio is 0, reflecting uncertainty in future earnings. The main risk is the recent trial failure which caused a significant drop in stock price, highlighting potential volatility ahead.
VTGN cerró en $0.24 el Tuesday, tras bajar -4.59%
Vistagen Therapeutics Inc (VTGN) last closed at $0.2433, losing -4.59%. These facts feed the 1-day and 1-week VTGN price prediction above.
Consenso de analistas
Vistagen Therapeutics Inc (VTGN): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Vistagen Therapeutics Inc (VTGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VTGN, ordenadas por similitud.
Análisis de estacionalidad de VTGN
Historically the probability of a positive September return for VTGN is 38.10%. October offers the highest probability of a positive month at 50.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.